My name is Guohui SUN, the Ph.D in Biomedical engineering. I am the full professor in College of Chemistry and Life Science, Beijing University of Technology. My research area focuses on the field of Molecular Toxicology and Applied Pharmacology. My H-index is 24. I have published over 50 academic papers indexed by SCIE. I am the Editorial board member of Scientific reports (SCI, IF:3.9), Frontiers in Bioscience-Landmark (SCI, IF:3.1) and World Journal of Clinical Oncology (IF:2.8); Young Editorial Board Member: IMed (IF:13.6, ESCI), Chemical Reagents (Chinese Core Journal). Dr. Sun received his Ph.D. degree from Beijing University of Technology, Beijing, China at July, 2017. Later, he worked as a Postdoctoral Research Associate in the same group for two years. After the Postdoctoral experience, he formally joined Beijing University of Technology as a professor and doctoral Supervisor. His major research interests include the mechanism of anticancer alkylating agents, tumor resistance, QSAR research in drug discovery and environmental toxicology. His main scientific contributions: a) proposed that dG-dC crosslinks can be a biomarker for evaluating the antitumor activity of chloroethylnitrosoureas; b) proposed that glycolytic inhibitors are very promising to reverse the clinical chemoresistance of anticancer agents; c) established predictive QSARomics models for environmental nitroaromatic compounds. He has a good contribution towards the scientific and academic community with numerous research publications in highly prestigious international journals and various presentations in both national and international conferences. He got the 2019 and 2020 MDPI outstanding reviewer’s representative award. He is the Editor board member of Scientific Reports (SCI indexed, IF:3.9), Frontiers in Bioscience-Landmark (SCI indexed, IF:3.3), the senior member of Chinese Pharmaceutical Association, the member of Chinese Chemical Society, Chinese Pharmacological Society and Chinese Society of Biomedical Engineering. My name is Guohui SUN, the Ph.D in Biomedical engineering. I am the professor in College of Chemistry and Life Science, Beijing University of Technology. My research area focuses on the field of Molecular Toxicology and Applied Pharmacology. My H-index is 24. I have published over 50 academic papers indexed by SCIE. I am the Editorial board member of Scientific reports (SCI, IF:3.9), Frontiers in Bioscience-Landmark (SCI, IF:3.1) and World Journal of Clinical Oncology (IF:2.8); Young Editorial Board Member: IMed (IF:13.6, ESCI), Chemical Reagents (Chinese Core Journal).